Loading
AU-007 is a monoclonal antibody from Aulos Bioscience, Inc., in registered phase 2 trials for metastatic cancer, melanoma, non-small-cell lung cancer.
AU-007 is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Aulos Bioscience, Inc., in metastatic cancer, melanoma, non-small-cell lung cancer, small-cell lung cancer. A monoclonal antibody, as described in the registry record. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
A monoclonal antibody, as described in the registry record.
1.AU-007 binds its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"AU-007" OR ABSTRACT:"AU-007") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about AU-007, not a curated reading list.
Shares Metastatic cancer (cancer that has spread), Small-cell lung cancer, Melanoma, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Metastatic cancer (cancer that has spread) and the tags pipeline, registry-only.